Peptide record

TPDB92427

WP2 Antibacterial Anticancer Toxicity modified_plain modified
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92427
WP2
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
modified_plain
Yes
A 14-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
C-terminal: Hydroxamic acid N-terminal: Acetylation
Sequence
Ac-RLLRLLRLRRLLRL
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
14 reviewed residue count
Hydroxamic acid Activity
L Activity
Linear Activity
Acetylation Activity
Anticancer Activity
Derived from RLL peptide Activity
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
IC50 = 0.446±0.095 µM
Anticancer
0.446

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

HDAC inhibition assay
Not Available

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 28.12 ± 1.5 µM
Anticancer
28.12

Target

Liver Cancer
Huh-7
Liver

Assay & Model

Cell Viability assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023
Evidence 3 Activity

Activity

IC50
IC50 = 34.05 ± 0.53 µM
Anticancer
34.05

Target

Liver Cancer
HepG-2
Liver

Assay & Model

Cell Viability assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023
Evidence 4 Activity

Activity

IC50
IC50 = 42.6 ± 4.0 µM
Anticancer
42.6

Target

Colon Cancer
HT-29
Colon

Assay & Model

Cell Viability assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023